Volume 62, Issue 6 , Pages 1013-1030, June 2010
Efficacy and safety of treatments for childhood psoriasis: A systematic literature review
To access this article, please choose from the options below
Supported by University Medical Center St Radboud Foundation, which received funding from Wyeth Pharmaceuticals for the project. Wyeth Pharmaceuticals played no role in the design and execution of the study or in data collection, data management, data analysis, interpretation of the data, manuscript preparation, manuscript review, or manuscript approval.
Conflicts of interest: None declared.
Disclosure: Dr de Jager participated in trials funded by Schering Plough and Abbott. Dr de Jong served as consultant for Biogen, Serono, Wyeth, and Abbott. She also received research grants from Merck Serono and Wyeth. Dr van de Kerkhof served as consultant for Schering Plough, Cellgene, Centocor, Allmirall, UCB, Wyeth, Pfizer, Soffinova, Abbott, Actelion, Galderma, Novartis, Janssen Cilag, and Leo Pharma. He also received research grants from Centocor, Wyeth, Schering Plough, Merck Serono, Abbott, and Philips Lighting. Dr Seyger has served as a consultant for Wyeth and participated in trials funded by Schering Plough and Wyeth.
PII: S0190-9622(09)00780-4
doi:10.1016/j.jaad.2009.06.048
© 2009 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
Volume 62, Issue 6 , Pages 1013-1030, June 2010
